Transarterial chemoembolization combined with lenvatinib plus tislelizumab for unresectable hepatocellular carcinoma: a multicenter cohort study

ObjectiveComparing the efficacy of transarterial chemoembolization (TACE) combined with lenvatinib plus tislelizumab (TLT) with TACE combined with lenvatinib (TL) for unresectable hepatocellular carcinoma, particularly in determining which patients can benefit more from the TLT treatment.MethodsFrom...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Yushan Zhao, Shuwei Wen, YaoQing Xue, Zhijun Dang, ZhiYu Nan, Dong Wang, Xiao Li, Duiping Feng, Yi Chen
Format:	Artigo
Jezik:	Inglês
Izdano:	Frontiers Media S.A. 2024-10-01
Serija:	Frontiers in Immunology
Teme:	TACE lenvatinib tislelizumab hepatocellular carcinoma overall survival
Online dostop:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1449663/full
Oznake:	Označite Brez oznak, prvi označite!